- Home»
- News & Events»
- Webinars»
- 2025 Payor Denial Impact Report: Maximizing Appeal Success in Diagnostics
2025 Payor Denial Impact Report: Maximizing Appeal Success in Diagnostics
Denials and appeals remain one of the most critical challenges impacting diagnostic reimbursement. With payors tightening policies and shifting reimbursement strategies, understanding the latest denial trends and benchmarks is essential for protecting revenue.
In this webinar, XiFin experts presented findings from the 2025 Payor Denial Impact Report, which analyzes more than 20 million claims across hospital outreach, molecular, and pathology testing. Attendees will gain insight into how denial rates and payor behavior have shifted, which appeal strategies are proving most effective, and how to measure the financial return of a strong appeals program.
This year’s session also introduces a new perspective: how artificial intelligence (AI) is driving measurable improvements in revenue cycle management. Jeff Carmichael, SVP of Engineering and Analytics, will share how embedded AI is being applied to denial prevention, predictive exception management, and reimbursement forecasting, helping laboratories achieve smarter, faster, and more predictable financial outcomes.
During this one-hour webinar, finance and revenue cycle leaders will learn how to:
- Interpret denial and appeal trends across hospital, molecular, and pathology segments
- Address top denial reasons by payor group to improve appeal success
- Evaluate your appeal success rates by comparing them with industry benchmarks
- Quantify the revenue and ROI impact of an effective appeals process
- Leverage embedded AI to reduce denials, streamline appeals, and improve reimbursement outcomes
Speakers
Diana Richard
AVP, National Accounts, Path/Rad/Hospital Systems
XiFin, Inc.
Diana Richard brings over 20 years of diagnostic provider billing experience to her role as Associate Vice President of National Accounts at XiFin, Inc. Specializing in Pathology, Radiology, and Hospital Systems, she serves as a strategic support liaison for XiFin’s diagnostic clients. Diana’s expertise extends to Anatomic Pathology, where she excels as a subject matter expert. She conducts routine data studies on reimbursement trends, utilizing her analytical skills to provide valuable insights to clients. Beyond analysis, Diana is a proficient communicator, sharing findings through presentations, webinars, blogs, and conference posters. Her dedication to driving innovation and excellence in diagnostic provider billing cements her reputation as a respected leader in the field.
Stephanie Denham
VP, RCM Systems and Analytics
XiFin, Inc.
Stephanie Denham, the Vice President of RCM Systems and Analytics at XiFin, Inc., brings over two decades of expertise in finance and revenue cycle management to her role. As an expert in systems, reporting, and analytics, Stephanie plays a pivotal role in leveraging data for strategic decision-making. She specializes in facilitating cross-customer analyses, focusing on productivity metrics and system functionalities utilization. By identifying opportunities in product development and workflow enhancement, Stephanie drives innovation and efficiency within XiFin’s operations. Her dedication to optimizing revenue cycle management processes has earned her a reputation as a trusted leader in the field. With her wealth of experience and analytical prowess, Stephanie continues to make significant contributions to the success of XiFin.
Jeff Carmichael
SVP, Engineering
XiFin, Inc.
Jeff’s engineering leadership spans more than 20 years and encompasses networking, security, and healthcare software and systems. He brings a career-long focus on data-driven insights and prediction through advanced data modeling across several industries. Prior to joining XiFin, Jeff led worldwide software development for the network and security division of LSI Corp. He has held senior-level leadership positions at several successful startups, and divisional leadership positions at Intel.
